ADNOCDRILL earnings per share for the last quarter are 0.08 AED whereas the estimation was 0.06 AED which accounts for 20.91% surprise. Company revenue for the same period amounts to 3.09 B AED despite the estimated figure of 3.03 B AED. Estimated earnings per share for the next quarter are 0.07 AED, and revenue is expected to reach 3.24 B AED. Also watch annual changes over time to get a bigger picture of ADNOCDRILL earnings per share and revenue dynamics.